Volume 87 Issue 39 | p. 35 | Concentrates
Issue Date: September 28, 2009

Animal-Health Deals In The Offing

Department: Business
Keywords: pharmaceuticals, animal health, merger
[+]Enlarge
Animal health is big business.
Credit: Merial
8739bcon_12
 
Animal health is big business.
Credit: Merial

To satisfy regulators before they merge, Pfizer and Wyeth have agreed to sell certain Wyeth animal-health assets to Boehringer Ingelheim. The German company will acquire vaccines and some drug products, primarily in the U.S. and Canada, along with research and manufacturing facilities located in Fort Dodge, Iowa. Boehringer may also gain certain other assets in Australia, South Africa, and the European Union, pending regulatory approvals. The companies did not disclose any financial details. Separately, Sanofi-Aventis has completed its $4 billion purchase of Merck & Co.’s 50% interest in their animal-health joint venture, Merial.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment